Case Report Forms and Study Data Sample Clauses

Case Report Forms and Study Data. 1.6 Záznamy subjektu hodnocení a Studijní údaje
Sample 1Sample 2Sample 3See All (11)
AutoNDA by SimpleDocs
Case Report Forms and Study Data a) PSI shall supply (or if electronic, provide access to) the forms to be used and completed by the Investigator to document a Study subject’s participation in the Study (the “Case Report Forms” or “CRFs”). The Investigator shall record all data generated as a result of conducting the Study (the “Study Data”) within 5 business days, in an accurate and complete manner, and shall ensure that the Case Report Forms for each Study subject are duly signed and dated. To the extent the Study requires completion of electronic Case Report Forms, the Institution and the Investigator shall ensure that they have implemented and maintain appropriate computer security sufficient to protect the confidentiality, integrity and availability of such Study Data in accordance with the Applicable Regulatory Requirements. The Investigator shall not grant unauthorized users access to the electronic data capture (EDC) system used in the Study, and in particular, shall not share or disclose his/her username and/or passwords.
Sample 1Sample 2Sample 3See All (7)
Case Report Forms and Study Data. 1.6 Záznamové formuláre účastníkov klinického skúšania a údaje skúšania
Sample 1Sample 2
Case Report Forms and Study Data a) PSI shall provide access to the electronic Case Report Forms to be used and completed by the Investigator to document a Study subject’s participation in the Study (the “Case Report Forms” or “CRFs”). The Investigator shall record all data generated as a result of conducting the Study (the “Study Data”) in a timely, true, correct, accurate and complete manner in source documents as defined by ICH GCP, and shall ensure that the Case Report Forms for each Study subject are duly signed and dated. The Institution and the Investigator will be responsible for data entry. Where specifically required for Data Adjudication Committee, data entry should occur within two (2) days of a subject visit. Otherwise data entry should occur within five (5) days of a subject visit. Study Personnel will be expected to respond to any electronic data queries within seven (7) days of their creation.
Sample 1Sample 2
Case Report Forms and Study Data a) PSI shall provide access to the electronic Case Report Forms to be used and completed by the Investigator to document a Study subject’s
Sample 1
Case Report Forms and Study Data a) The Sponsor shall supply (or if electronic, provide access to) the forms to be used and completed by the Investigator to document a Study subject’s participation in the Study (the “Case Report Forms” or “CRFs”). The Investigator shall record all data generated as a result of conducting the Study (the “Study Data”). Study data should be attributable, legible, contemporaneous, original, accurate, complete, and recorded in a timely, accurate and complete manner, and the Investigator shall ensure that the Case Report Forms for each Study subject are duly signed and dated. The
Sample 1
Case Report Forms and Study Data a) The Investigator shall record all data resulting from the Study (the “Study Data”) in an accurate, legible and complete manner. The Institution acknowledges and agrees that the Sponsor shall own all Study Data and Study results.
Sample 1
AutoNDA by SimpleDocs
Case Report Forms and Study Data. 1.6 Xxxxxx xxxxxxxxxx xxxxxx x Xxxxxxxx xxxxx
Sample 1
Case Report Forms and Study Data. (a) PSI shall supply to the Investigative Site forms to be used and completed by the Investigator to document a Study Subject’s participation in the Study (such forms are referred to as “Electronic Case Report Forms”). The Investigative Site shall ensure that the Investigator reviews all patient Electronic Case Report Forms to assure their accuracy and completeness, and assist PSI and its representatives (including clinical monitors) upon their request in prompt resolution of any discrepancies or errors contained in the Electronic Case Report Forms and in review, verification, inspection and/or auditing of the Study Subjects’ records, laboratory reports, or other raw data sources supporting the data recorded on the Electronic Case Report Forms. The Investigative Site shall ensure that the Investigator signs and dates the Electronic Case Report Forms for each Study Subject. (b) The Investigative Site shall ensure that the Investigator records all data generated as a result of conducting the Study (the “Study Data”) in a timely, accurate, complete, and legible manner in the form described in the Protocol. The Investigative Site shall take reasonable and customary precautions to prevent the loss or alteration of any Study Data. The Investigative Site acknowledges and agrees that the Sponsor shall own all Study Data. 1.5 Záznamy subjektu hodnocení a Údaje Studie. (a) PSI dodá Zdravotnickému zařízení formuláře, které má Hlavní zkoušející používat a vyplnit pro zdokumentování účasti Subjektů hodnocení na Studii (tyto formuláře se nazývají „Elektronické záznamy subjektu hodnocení“). Zdravotnické zařízení zajistí, že Hlavní zkoušející bude prověřovat všechny Elektronické záznamy subjektu hodnocení pacientů, aby zajistil jejich přesnost a úplnost, a bude PSI a jejím zástupcům (včetně klinického dozoru) pomáhat na jejich žádost při urychleném řešení jakýchkoliv nesrovnalostí nebo chyb v Elektronických záznamech subjektu hodnocení a xxx xxxxxx, xxxxxxxxx, xxxxxxxx a (nebo) auditu elektronických záznamů o Subjektech hodnocení, laboratorních hlášení nebo jiných zdrojů nezpracovaných údajů zaznamenaných Záznamech subjektu hodnocení. Zdravotnické zařízení zajistí, že Hlavní zkoušející bude podepisovat a datovat elektronické záznamy subjektu hodnocení, a to pro každý Subjekt hodnocení. (b) Zdravotnické zařízení zajistí, že Hlavní zkoušející bude zaznamenávat veškeré údaje generované v důsledku provádění Studie („Údaje Studie“), a to včas, přesně, úplně a čitelně ve formě ...
Sample 1

Related to Case Report Forms and Study Data

  • REPORT SUBMISSION 1. Copies of reporting packages for audits conducted in accordance with 2 CFR Part 200, Subpart F-Audit Requirements, and required by PART I of this form shall be submitted, when required by 2 CFR 200.512, by or on behalf of the recipient directly to the Federal Audit Clearinghouse (FAC) as provided in 2 CFR 200.36 and 200.512

  • Report Format The Project Schedule shall be presented primarily in a bar-chart format, as well as additional tabular or matrix reports that may be requested.

  • GRIEVANCE REPORT FORM Grievance # School District Distribution of Form 1. Superintendent

  • AUDIT REPORT SUBMISSION Audit reports must be submitted no later than 150 days following cancellation, termination or expiration of this Agreement.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. How to File an Expedited Appeal Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

  • Progress Reports The Recipient shall submit to the OPWC, at the OPWC's request, summary reports detailing the progress of the Project pursuant to this Agreement and any additional reports containing such information as the OPWC may reasonably require.

  • Progress Report 10.1 If required, you shall submit progress reports in connection with the Service (“Report”) on at least a monthly basis, or as we may require. The Report shall include a summary of the activities and accomplishments during the previous reporting period.

  • Progress Reporting 5. The IP will submit to UNICEF narrative progress reports against the planned activities contained in the Programme Document, using the PDPR. Unless otherwise agreed between the Parties in writing, these reports will be submitted at the end of every Quarter. The final report will be submitted no later than thirty (30) calendar days after the end the Programme and will be provided together with the FACE form.

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Joint Review JADRC may, at the request of either party, review issues arising from the application of this Article.

Time is Money Join Law Insider Premium to draft better contracts faster.